KR102515555B1 - 세균성 감염 및 바이러스성 감염의 진단 방법 - Google Patents

세균성 감염 및 바이러스성 감염의 진단 방법 Download PDF

Info

Publication number
KR102515555B1
KR102515555B1 KR1020187035585A KR20187035585A KR102515555B1 KR 102515555 B1 KR102515555 B1 KR 102515555B1 KR 1020187035585 A KR1020187035585 A KR 1020187035585A KR 20187035585 A KR20187035585 A KR 20187035585A KR 102515555 B1 KR102515555 B1 KR 102515555B1
Authority
KR
South Korea
Prior art keywords
patient
bacterial
viral
delete delete
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187035585A
Other languages
English (en)
Korean (ko)
Other versions
KR20190015294A (ko
Inventor
펄베쉬 카트리
티모시 이. 스위니
Original Assignee
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 filed Critical 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티
Priority to KR1020237010265A priority Critical patent/KR20230049750A/ko
Publication of KR20190015294A publication Critical patent/KR20190015294A/ko
Application granted granted Critical
Publication of KR102515555B1 publication Critical patent/KR102515555B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020187035585A 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법 Active KR102515555B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237010265A KR20230049750A (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662346962P 2016-06-07 2016-06-07
US62/346,962 2016-06-07
PCT/US2017/036003 WO2017214061A1 (en) 2016-06-07 2017-06-05 Methods for diagnosis of bacterial and viral infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020237010265A Division KR20230049750A (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법

Publications (2)

Publication Number Publication Date
KR20190015294A KR20190015294A (ko) 2019-02-13
KR102515555B1 true KR102515555B1 (ko) 2023-03-28

Family

ID=60578903

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020187035585A Active KR102515555B1 (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법
KR1020247021226A Active KR102915694B1 (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법
KR1020237010265A Ceased KR20230049750A (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020247021226A Active KR102915694B1 (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법
KR1020237010265A Ceased KR20230049750A (ko) 2016-06-07 2017-06-05 세균성 감염 및 바이러스성 감염의 진단 방법

Country Status (11)

Country Link
US (2) US11274345B2 (enExample)
EP (1) EP3464645A4 (enExample)
JP (2) JP2019520042A (enExample)
KR (3) KR102515555B1 (enExample)
CN (1) CN109312411A (enExample)
AU (3) AU2017278254A1 (enExample)
BR (1) BR112018075288A2 (enExample)
CA (1) CA3022616A1 (enExample)
IL (2) IL312537B2 (enExample)
MX (2) MX2018015184A (enExample)
WO (1) WO2017214061A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250075010A (ko) 2023-11-21 2025-05-28 바디텍메드(주) 믹소바이러스 내성 단백질 a와 c-반응성 단백질을 이용한 박테리아감염과 바이러스감염 구별을 위한 진단 시스템

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3759235B1 (en) 2018-02-27 2025-02-19 The Board Of Trustees Of The Leland Stanford Junior University Classifier for identification of robust sepsis subtypes
GB201806052D0 (en) * 2018-04-12 2018-05-30 Univ Liverpool Detection of bacterial infections
US12110564B2 (en) 2018-05-07 2024-10-08 Yale University Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
CA3135429A1 (en) 2018-08-04 2020-02-13 Imperial College Innovations Limited Method of identifying a subject having kawasaki disease
CA3117201A1 (en) * 2018-09-19 2020-03-26 Inflammatix, Inc. Assessing host rna using isothermal amplification and relative abundance
EP4462388A3 (en) * 2018-10-09 2025-01-22 Light AI Inc. Image processing of streptococcal infection in pharyngitis subjects
US11369318B2 (en) 2019-05-31 2022-06-28 Light Ai, Inc. Image processing of streptococcal infection in pharyngitis subjects
EP3921446A1 (en) * 2019-02-05 2021-12-15 Universidade de Santiago de Compostela In vitro method for the diagnosis of viral infections
CA3133639A1 (en) * 2019-03-22 2020-10-01 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
CN113785074A (zh) * 2019-03-25 2021-12-10 斯坦福大学托管董事会 用于诊断细菌感染与病毒感染的特征
US11104946B2 (en) * 2019-04-23 2021-08-31 Inflammatix, Inc. DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome
CN110082338A (zh) * 2019-05-15 2019-08-02 广西科技大学 超顺磁性Fe3O4@SiO2@Ag纳米复合材料用于对苯唑西林SERS检测的方法
EP3817005A1 (en) * 2019-11-01 2021-05-05 Koninklijke Philips N.V. System for infection diagnosis
IL292945A (en) * 2019-11-13 2022-07-01 Univ Colorado Regents Identification of rna-type biological markers for infection in the warehouse
WO2021117044A1 (en) 2019-12-11 2021-06-17 Ichilov Tech Ltd. Non-invasive assay for differentiating between bacterial and viral infections
EP4629189A3 (en) 2020-03-19 2025-12-24 Light AI Inc. Infection detection using image data analysis
WO2021192320A1 (ja) * 2020-03-27 2021-09-30 株式会社島津製作所 新型コロナウイルスの検査方法および検査試薬
KR102422238B1 (ko) * 2020-04-27 2022-07-18 경북대학교 산학협력단 TGFBIp의 아세틸화 수준을 측정하는 제제를 포함하는 중증급성호흡기증후군 바이러스 2 진단용 조성물
US11644456B2 (en) * 2020-04-28 2023-05-09 Brandon Heeger Rapid testing mechanism and method for respiratory viral pathogens
CN111848772B (zh) * 2020-08-03 2022-03-18 山东绿都生物科技有限公司 SAMD9突变型蛋白、Vero细胞系及其构建方法和应用
US20230314433A1 (en) * 2020-08-25 2023-10-05 Kurume University Method of determining viral infection
EP4308729B1 (en) * 2021-03-16 2025-10-29 Cepheid Methods for discriminating bacterial and viral infections in a human subject
US20220399116A1 (en) * 2021-05-04 2022-12-15 Inflammatix, Inc. Systems and methods for assessing a bacterial or viral status of a sample
CN115029426B (zh) * 2022-04-19 2025-05-27 武汉大学中南医院 冠心病诊断剂及dysf基因甲基化在制备冠心病诊断剂中的应用
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate
WO2025059317A1 (en) * 2023-09-13 2025-03-20 President And Fellows Of Harvard College Transcriptomic signatures for identifying drug-susceptible mycobacterium tuberculosis complex
CN118127149B (zh) * 2024-05-10 2024-07-09 天津云检医学检验所有限公司 一种用于评估受试者的败血症风险和感染型的生物标志物、模型及试剂盒
CN119479830B (zh) * 2025-01-15 2025-05-16 北京大学 一种多中心数据聚合方法
CN121380333B (zh) * 2025-12-20 2026-04-21 广东辉锦创兴生物医学科技有限公司 通过检测宿主外周血基因表达鉴别待测样品感染类别的试剂盒及其方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110275542A1 (en) * 2010-04-21 2011-11-10 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
JP2015510122A (ja) * 2012-02-09 2015-04-02 メメド ダイアグノスティクス リミテッド 感染を診断するための特徴および決定因子ならびにその使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040038201A1 (en) 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
WO2007059119A2 (en) * 2005-11-11 2007-05-24 Ivan Borozan Systems and methods for identifying diagnostic indicators
NZ573052A (en) 2006-04-26 2012-03-30 Vertex Pharma Hepatitis c virus infection biomarkers
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
GB201201766D0 (en) * 2012-02-01 2012-03-14 Imp Innovations Ltd Method
WO2013162651A1 (en) * 2012-04-28 2013-10-31 Us Army Center For Environmental Health Research(Cehr) Biomarkers of immune dysfunction in response to chronic stress, methods of use and diagnostic kits
HK1206071A1 (en) * 2012-05-08 2015-12-31 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for providing a preeclampsia assessment
CN109504768A (zh) * 2013-03-15 2019-03-22 威拉赛特公司 用于诊断肺病的生物标记物及其使用方法
WO2014209238A1 (en) * 2013-06-28 2014-12-31 Acumen Research Laboratories Pte. Ltd. Sepsis biomarkers and uses thereof
JP2016530545A (ja) * 2013-09-17 2016-09-29 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 卵巣がんに関するバイオマーカー
WO2015048098A1 (en) * 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
GB201406259D0 (en) * 2014-04-07 2014-05-21 Univ Edinburgh Molecular predictors of neonatal sepsis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110275542A1 (en) * 2010-04-21 2011-11-10 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
JP2015510122A (ja) * 2012-02-09 2015-04-02 メメド ダイアグノスティクス リミテッド 感染を診断するための特徴および決定因子ならびにその使用方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Timothy E. Sweeney et al., Sci. Transl. Med., 7(287), 287ra71, 2015.*

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250075010A (ko) 2023-11-21 2025-05-28 바디텍메드(주) 믹소바이러스 내성 단백질 a와 c-반응성 단백질을 이용한 박테리아감염과 바이러스감염 구별을 위한 진단 시스템

Also Published As

Publication number Publication date
US20220127673A1 (en) 2022-04-28
AU2023226757A1 (en) 2023-09-28
JP2019520042A (ja) 2019-07-18
IL312537B1 (en) 2025-09-01
JP2023098945A (ja) 2023-07-11
IL312537B2 (en) 2026-01-01
IL262762B1 (en) 2024-06-01
AU2023226757B2 (en) 2026-05-07
CA3022616A1 (en) 2017-12-14
MX2018015184A (es) 2019-04-24
BR112018075288A2 (pt) 2019-03-19
AU2017278254A1 (en) 2018-11-15
KR102915694B1 (ko) 2026-01-20
JP7750895B2 (ja) 2025-10-07
US20190144943A1 (en) 2019-05-16
KR20190015294A (ko) 2019-02-13
EP3464645A4 (en) 2020-05-06
KR20240100488A (ko) 2024-07-01
US11274345B2 (en) 2022-03-15
WO2017214061A1 (en) 2017-12-14
IL312537A (en) 2024-07-01
KR20230049750A (ko) 2023-04-13
IL262762B2 (en) 2024-10-01
CN109312411A (zh) 2019-02-05
IL262762A (en) 2018-12-31
MX2024009339A (es) 2024-08-09
EP3464645A1 (en) 2019-04-10
AU2026202889A1 (en) 2026-05-07

Similar Documents

Publication Publication Date Title
JP7750895B2 (ja) 細菌感染及びウイルス感染を診断するための方法
US20210348233A1 (en) Methods for Diagnosis of Tuberculosis
US20240011096A1 (en) Biomarkers for use in prognosis of mortality in critically ill patients
WO2022235765A2 (en) Systems and methods for assessing a bacterial or viral status of a sample
WO2020096796A1 (en) Method for predicting severe dengue

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20181207

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200604

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210330

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20211026

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210330

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20211026

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210528

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20200602

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220203

Patent event code: PE09021S01D

AMND Amendment
PX0701 Decision of registration after re-examination

Patent event date: 20221226

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20220802

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20211227

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20211026

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20210528

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200602

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230324

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230324

End annual number: 3

Start annual number: 1

PG1601 Publication of registration